Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs; Guidance for Industry; Draft Guidance
FDA-2018-D-3546-0014Other
Comments
0
Awaiting comments
Deadline
60 days
Closes Oct 3, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from the source system.
- Title
- Assessing the Irritation and Sensitization Potential of Transdermal and Topical Delivery Systems for ANDAs; Guidance for Industry; Draft Guidance
Revision 2
- Posted
- Aug 3, 2026
- Comment period
- Aug 3, 2026 – Oct 3, 2026
- Topics
Analysis
Overview
No comments yet — comment period open · 60 days left.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
No comments match.